Armitage James O

Armitage James O is listed in filings as Director at Cardiff Oncology, Inc.. This profile follows SEC Form 4 activity through Jun 15, 2026, including 3 public disclosures. Recent filings connect the profile to Cardiff Oncology, Inc. (CRDF). The current snapshot covers public activity from Jul 1, 2024 to Jun 15, 2026. Reported amounts are shown as $64.5K to $128.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.